Northern Trust’s Phio Pharmaceuticals PHIO Stock Holding History

Northern Trust’s Portfolio PHIO Stock Details PHIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.5K	Buy	27,768 +4,010	+17%	+$4.57K	﹤0.01%	4338
2026 Q1	$29K	Hold	23,758	–	–	﹤0.01%	4310
2025 Q4	$24.9K	Buy	+23,758	New	+$38K	﹤0.01%	4372
2018 Q1	–	Hold	0	–	-$7K	–	4273
2017 Q4	–	Hold	0	–	–	–	4205
2017 Q3	–	Hold	0	–	–	–	4217
2017 Q2	–	Hold	0	–	–	–	4234
2017 Q1	–	Hold	0	–	–	–	4200
2016 Q2	–	Hold	0	–	-$3K	–	4258
2016 Q1	–	Hold	0	–	–	–	4215
2015 Q4	–	Hold	0	–	–	–	4235
2015 Q3	–	Hold	0	–	–	–	4247
2015 Q2	–	Hold	0	–	–	–	4194
2015 Q1	–	Hold	0	–	–	–	4259
2014 Q4	–	Hold	0	–	–	–	4166
2014 Q3	–	Hold	0	–	–	–	4185
2014 Q2	–	Hold	0	–	–	–	4119
2014 Q1	–	Hold	0	–	–	–	4016

Other funds holding PHIO

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Northern Trust's PHIO Position: Q2 2026 in Review

Northern Trust increased its Phio Pharmaceuticals (PHIO) stake by 17% in Q2 2026, buying an estimated $4.57K and bringing the position to 27,768 shares worth $28.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4338.

Northern Trust first reported a position in PHIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $29K in Q1 2026. 24 funds tracked by Wall St. Rank hold PHIO as of Q2 2026.

Northern Trust held 27,768 shares of Phio Pharmaceuticals worth $28.5K as of Q2 2026.
Northern Trust bought 4,010 Phio Pharmaceuticals shares in Q2 2026, an estimated $4.57K.
Phio Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4338 holding.
Northern Trust first reported a position in Phio Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
Northern Trust's Phio Pharmaceuticals position peaked at $29K in Q1 2026.
24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.